- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 305/06 - Hydrogenosulfates
Patent holdings for IPC class C07C 305/06
Total number of patents in this class: 50
10-year publication summary
|
3
|
4
|
5
|
1
|
3
|
3
|
4
|
5
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Handa Oncology, LLC | 25 |
6 |
| BASF SE | 21320 |
4 |
| Translate bio, Inc. | 416 |
3 |
| Mainstream Pine Products, LLC | 60 |
3 |
| The Procter & Gamble Company | 21862 |
2 |
| Allergan, Inc. | 2148 |
2 |
| Lawrence Livermore National Security, LLC | 1983 |
2 |
| Arkema France | 4231 |
2 |
| Harcros Chemicals Inc. | 33 |
2 |
| Ultimate EOR Services, LLC | 11 |
2 |
| Specialty Operations France | 937 |
2 |
| F. Hoffmann-La Roche AG | 7798 |
1 |
| Hoffmann-La Roche Inc. | 3841 |
1 |
| Halliburton Energy Services, Inc. | 21292 |
1 |
| Merck Patent GmbH | 5747 |
1 |
| ExxonMobil Chemical Patents Inc. | 3762 |
1 |
| Rohm and Haas Company | 2943 |
1 |
| Dow Global Technologies LLC | 11051 |
1 |
| Board of Regents, The University of Texas System | 6172 |
1 |
| Korea Institute of Science and Technology | 2255 |
1 |
| Other owners | 11 |